image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 544.47
0.716 %
$ 195 B
Market Cap
79.72
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one ISRG stock under the worst case scenario is HIDDEN Compared to the current market price of 544 USD, Intuitive Surgical, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one ISRG stock under the base case scenario is HIDDEN Compared to the current market price of 544 USD, Intuitive Surgical, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 6, 2025.

The intrinsic value of one ISRG stock under the best case scenario is HIDDEN Compared to the current market price of 544 USD, Intuitive Surgical, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ISRG

image
$620.0$620.0$600.0$600.0$580.0$580.0$560.0$560.0$540.0$540.0$520.0$520.0$500.0$500.0$480.0$480.0$460.0$460.0$440.0$440.015 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '25
FINANCIALS
8.35 B REVENUE
17.24%
2.35 B OPERATING INCOME
32.95%
2.34 B NET INCOME
28.62%
2.42 B OPERATING CASH FLOW
33.15%
-3.27 B INVESTING CASH FLOW
-808.86%
151 M FINANCING CASH FLOW
152.47%
2.25 B REVENUE
-6.63%
578 M OPERATING INCOME
-21.34%
704 M NET INCOME
2.28%
582 M OPERATING CASH FLOW
-29.30%
214 M INVESTING CASH FLOW
116.89%
-236 M FINANCING CASH FLOW
-477.33%
Balance Sheet Intuitive Surgical, Inc.
image
Current Assets 7.11 B
Cash & Short-Term Investments 4.01 B
Receivables 1.36 B
Other Current Assets 1.74 B
Non-Current Assets 11.6 B
Long-Term Investments 4.9 B
PP&E 4.78 B
Other Non-Current Assets 1.95 B
21.41 %7.24 %9.29 %26.16 %25.52 %10.38 %Total Assets$18.7b
Current Liabilities 1.75 B
Accounts Payable 193 M
Short-Term Debt 33.5 M
Other Current Liabilities 1.52 B
Non-Current Liabilities 468 M
Long-Term Debt 112 M
Other Non-Current Liabilities 356 M
8.74 %68.59 %5.08 %16.07 %Total Liabilities$2.2b
EFFICIENCY
Earnings Waterfall Intuitive Surgical, Inc.
image
Revenue 8.35 B
Cost Of Revenue 2.72 B
Gross Profit 5.63 B
Operating Expenses 3.29 B
Operating Income 2.35 B
Other Expenses 11.4 M
Net Income 2.34 B
9b9b8b8b7b7b6b6b5b5b4b4b3b3b2b2b1b1b008b(3b)6b(3b)2b(11m)2bRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
67.46% GROSS MARGIN
67.46%
28.12% OPERATING MARGIN
28.12%
27.81% NET MARGIN
27.81%
14.13% ROE
14.13%
12.39% ROA
12.39%
12.06% ROIC
12.06%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Intuitive Surgical, Inc.
image
2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 2.34 B
Depreciation & Amortization 462 M
Capital Expenditures -1.11 B
Stock-Based Compensation 677 M
Change in Working Capital -919 M
Others 300 K
Free Cash Flow 1.3 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Intuitive Surgical, Inc.
image
Wall Street analysts predict an average 1-year price target for ISRG of $537 , with forecasts ranging from a low of $410 to a high of $650 .
ISRG Lowest Price Target Wall Street Target
410 USD -24.70%
ISRG Average Price Target Wall Street Target
537 USD -1.40%
ISRG Highest Price Target Wall Street Target
650 USD 19.38%
Price
Max Price Target
Min Price Target
Average Price Target
650650600600550550500500450450400400Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 14
6. Ownership
Insider Ownership Intuitive Surgical, Inc.
image
Sold
0-3 MONTHS
6.47 M USD 7
3-6 MONTHS
31.7 M USD 10
6-9 MONTHS
30.6 M USD 6
9-12 MONTHS
28.9 M USD 8
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
2 Unstoppable Growth Stocks to Hold for the Next 20 Years The stock market has an incredibly impressive long-term track record of wealth creation, and we can reasonably expect it to continue delivering excellent returns over the next 20 years. Investors can capitalize on this by buying ETFs that track major indexes, or by investing in individual stocks that can perform as well, if not better, than broader equities. fool.com - 1 week ago
Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet. zacks.com - 1 week ago
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store. zacks.com - 1 week ago
Prediction: 3 Magnificent Stocks That'll Be Worth More Than Palantir by 2028 Since late 2022, no investment trend has been hotter on Wall Street than the evolution of artificial intelligence (AI). Allowing AI-empowered software and systems to make split-second decisions and grow more efficient at their tasks over time is a game-changing technology that offers utility in most industries around the globe. fool.com - 1 week ago
Intuitive's da Vinci 5 Surgical System Receives CE Mark Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures globenewswire.com - 1 week ago
Can ISRG Maintain Robotics Edge Amid Rising Rivalry & Budget Strain? ISRG posted strong Q1 growth, but rising rivals and tighter hospital budgets test its robotics dominance and pricing power. zacks.com - 1 week ago
2 Stocks to Profit From What Nvidia's CEO Calls a Multi-Trillion-Dollar Industry Key Points in This Article: The robotics industry, projected to grow from $71.2 billion in 2023 to $200 billion by 2030, is driven by AI advancements and demand for automation in logistics and healthcare. 247wallst.com - 2 weeks ago
Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $534.38, denoting a +2.44% move from the preceding trading day. zacks.com - 2 weeks ago
Wall Street Analysts See Intuitive Surgical (ISRG) as a Buy: Should You Invest? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? zacks.com - 2 weeks ago
Is ISRG's Procedure Growth Enough to Offset Margin Pressures in 2025? Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins. zacks.com - 2 weeks ago
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $515.09, marking a +1.12% move from the previous day. zacks.com - 2 weeks ago
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. zacks.com - 3 weeks ago
8. Profile Summary

Intuitive Surgical, Inc. ISRG

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 195 B
Dividend Yield 0.00%
Description Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Contact 1020 Kifer Road, Sunnyvale, CA, 94086-5304 https://www.intuitive.com
IPO Date June 16, 2000
Employees 15638
Officers Dr. Gary S. Guthart Ph.D. Chief Executive Officer & Director Mr. Milind Wagle Chief Information Officer Mr. Brian King Vice President, Treasurer & Head of Investor Relations Mr. Gary H. Loeb J.D. Executive Vice President and Chief Legal & Compliance Officer Dr. Christopher R. Carlson Ph.D. Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures Dr. Brian E. Miller Ph.D. Executive Vice President & Chief Digital Officer Mr. Fredrik Widman Vice President, Principal Accounting Officer & Corporate Controller Mr. David J. Rosa President & Director Mr. Jamie E. Samath Executive Vice President, Chief Financial Officer and Head of Business Technology Mr. Henry L. Charlton Executive Vice President and Chief Commercial & Marketing Officer